AgingResearch.News
Frontiers in Immunology

The association between SGLT2 inhibitors and rheumatoid arthritis risk in type 2 diabetes: findings from large-scale emulated target trials

By Fu-Shun Yen, Shiow-Ing Wang, Chih-Cheng Hsu, Show 2 more authorsJames Cheng-Chung Wei
Figure 1 from Frontiers in Immunology
Open the figure at full size
Figure 1. Yen et al.
Cohort study in peoplePopulations

Multicentre, declared no competing interests

Paper

The paper

Fu-Shun Yen, Shiow-Ing Wang, Chih-Cheng Hsu, Show 2 more authorsJames Cheng-Chung Wei

Dr. Yen’s Clinic; Chung Shan Medical University

Frontiers in Immunology, 4 Aug 2026

doi.org/10.3389/fimmu.2026.1867117PubMed 42614254

More on SGLT2 inhibitors